Home
>
National Drug Code (NDC)
>
AZILECT
AZILECT - 68546-229-27 - (rasagiline mesylate)
Drug Information of AZILECT
| Product NDC: | 68546-229 |
| Proprietary Name: | AZILECT |
| Non Proprietary Name: | rasagiline mesylate |
| Active Ingredient(s): | 1 mg/1 & nbsp; rasagiline mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AZILECT
| Product NDC: | 68546-229 |
| Labeler Name: | Teva Neuroscience, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021641 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090609 |
Package Information of AZILECT
| Package NDC: | 68546-229-27 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (68546-229-27) > 7 TABLET in 1 BLISTER PACK |
NDC Information of AZILECT
| NDC Code | 68546-229-27 |
| Proprietary Name | AZILECT |
| Package Description | 1 BLISTER PACK in 1 CARTON (68546-229-27) > 7 TABLET in 1 BLISTER PACK |
| Product NDC | 68546-229 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rasagiline mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090609 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Neuroscience, Inc. |
| Substance Name | RASAGILINE MESYLATE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
